Literature DB >> 30729352

Acidosis promotes tumorigenesis by activating AKT/NF-κB signaling.

Liu Yang1, Xiaoge Hu1,2, Yin-Yuan Mo3.   

Abstract

The microenvironment of solid tumors is often acidic due to poor vascular perfusion, regional hypoxia, and increased glycolytic activity of tumor cells. Although acidosis is harmful to most types of cells, tumor cells seem well adapted to such harsh conditions. Moreover, overwhelming evidence indicates that tumor cells are more invasive and more aggressive in acidic conditions by a cascade of cell signaling and upregulation of oncogenic gene expression. Therefore, how extracellular acidic signals are transduced to the cytoplasm and then into the nucleus is an interesting topic to many cancer researchers. In this review, we update on the recent advances in acidosis-induced tumorigenesis through the acid-sensing ion channels (ASICs) and activation of cell signaling.

Entities:  

Keywords:  AKT/NF-κB signaling; Acidosis; Acidosis-induced tumorigenesis

Mesh:

Substances:

Year:  2019        PMID: 30729352     DOI: 10.1007/s10555-019-09785-6

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN: 0167-7659            Impact factor:   9.264


  11 in total

1.  Acid-sensing ion channel 1 (ASIC1) mediates weak acid-induced migration of human malignant glioma cells.

Authors:  Yulan Sheng; Baoming Wu; Tiandong Leng; Li Zhu; Zhigang Xiong
Journal:  Am J Cancer Res       Date:  2021-03-01       Impact factor: 6.166

2.  Lupeol protects against cardiac hypertrophy via TLR4-PI3K-Akt-NF-κB pathways.

Authors:  Dan Li; Ying-Ying Guo; Xian-Feng Cen; Hong-Liang Qiu; Si Chen; Xiao-Feng Zeng; Qian Zeng; Man Xu; Qi-Zhu Tang
Journal:  Acta Pharmacol Sin       Date:  2021-12-16       Impact factor: 7.169

3.  Micropeptide CIP2A-BP encoded by LINC00665 inhibits triple-negative breast cancer progression.

Authors:  Binbin Guo; Siqi Wu; Xun Zhu; Liyuan Zhang; Jieqiong Deng; Fang Li; Yirong Wang; Shenghua Zhang; Rui Wu; Jiachun Lu; Yifeng Zhou
Journal:  EMBO J       Date:  2019-11-22       Impact factor: 11.598

4.  miR-940 regulates the inflammatory response of chondrocytes by targeting MyD88 in osteoarthritis.

Authors:  Jian Cao; Zhongxing Liu; Limin Zhang; Jinlong Li
Journal:  Mol Cell Biochem       Date:  2019-08-21       Impact factor: 3.842

Review 5.  Galectin-8, cytokines, and the storm.

Authors:  Yehiel Zick
Journal:  Biochem Soc Trans       Date:  2022-02-28       Impact factor: 4.919

6.  Integrin β3 promotes cardiomyocyte proliferation and attenuates hypoxia-induced apoptosis via regulating the PTEN/Akt/mTOR and ERK1/2 pathways.

Authors:  Lijiang Wei; Qingqing Zhou; Hua Tian; Yifan Su; Guo-Hui Fu; Ting Sun
Journal:  Int J Biol Sci       Date:  2020-01-14       Impact factor: 6.580

7.  Therapeutic Potential of Triptolide as an Anti-Inflammatory Agent in Dextran Sulfate Sodium-Induced Murine Experimental Colitis.

Authors:  Bufu Tang; Jinyu Zhu; Baohui Zhang; Fazong Wu; Yajie Wang; Qiaoyou Weng; Shiji Fang; Liyun Zheng; Yang Yang; Rongfang Qiu; Minjiang Chen; Min Xu; Zhongwei Zhao; Jiansong Ji
Journal:  Front Immunol       Date:  2020-11-09       Impact factor: 7.561

8.  Acidic Urine Is Associated With Poor Prognosis of Upper Tract Urothelial Carcinoma.

Authors:  Jang Hee Han; Seung-Hwan Jeong; Hyeong Dong Yuk; Chang Wook Jeong; Cheol Kwak; Ja Hyeon Ku
Journal:  Front Oncol       Date:  2022-01-24       Impact factor: 6.244

9.  Identification of distinct slow mode of reversible adaptation of pancreatic ductal adenocarcinoma to the prolonged acidic pH microenvironment.

Authors:  Tzu-Chin Wu; Chien-Yu Liao; Wei-Chien Lu; Chuang-Rung Chang; Fang-Yu Tsai; Shih-Sheng Jiang; Tsung-Hsien Chen; Kurt Ming-Chao Lin; Li-Tzong Chen; Wun-Shaing Wayne Chang
Journal:  J Exp Clin Cancer Res       Date:  2022-04-11

10.  TAB2 Promotes the Biological Functions of Head and Neck Squamous Cell Carcinoma Cells via EMT and PI3K Pathway.

Authors:  Huijuan Liu; Hui Zhang; Haidong Fan; Su Tang; Junquan Weng
Journal:  Dis Markers       Date:  2022-08-08       Impact factor: 3.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.